Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain
A Tagarro, C Epalza, M Santos… - JAMA …, 2021 - jamanetwork.com
Methods With the aim of obtaining an overview of the proportion of confirmed cases among
those tested and the severity of the disease in children, a registry of tested cases was …
those tested and the severity of the disease in children, a registry of tested cases was …
[HTML][HTML] Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 …
Background Improving the quality of hospital antibiotic use is a major goal of WHO's global
action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access …
action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access …
Multi-inflammatory syndrome in children related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Spain
C Moraleda, M Serna-Pascual… - Clinical Infectious …, 2021 - academic.oup.com
Some clusters of children with a multisystem inflammatory syndrome (MIS-C) associated
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been …
High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants
C Epalza, T Goetghebuer, M Hainaut, F Prayez… - …, 2010 - publications.aap.org
OBJECTIVES: The occurrence of an unusual number of group B streptococcal (GBS)
infections in HIV-exposed uninfected (HEU) infants who were followed in our center …
infections in HIV-exposed uninfected (HEU) infants who were followed in our center …
[HTML][HTML] Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children
A Tagarro, E Cobos-Carrascosa, S Villaverde… - European Journal of …, 2022 - Springer
We aimed to identify the spectrum of disease in children with COVID-19, and the risk factors
for admission in paediatric intensive care units (PICUs). We conducted a multicentre …
for admission in paediatric intensive care units (PICUs). We conducted a multicentre …
[HTML][HTML] Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old
D Blázquez-Gamero, C Epalza, JAA Cadenas… - European journal of …, 2021 - Springer
Fever without source (FWS) in infants is a frequent cause of consultation at the emergency
department, and the emergence of SARS-CoV-2 could affect the approach to those infants …
department, and the emergence of SARS-CoV-2 could affect the approach to those infants …
Prevalence and clinical manifestations of congenital cytomegalovirus infection in a screening program in Madrid (PICCSA study)
D Blázquez-Gamero, M Soriano-Ramos… - The Pediatric …, 2020 - journals.lww.com
Background: Cytomegalovirus (CMV) is the leading cause of congenital infection worldwide.
Up to 15%–20% of infected newborns will develop long-term sequelae such as hearing loss …
Up to 15%–20% of infected newborns will develop long-term sequelae such as hearing loss …
SARS‐CoV‐2 acute bronchiolitis in hospitalized children: Neither frequent nor more severe
D Andina‐Martinez, JA Alonso‐Cadenas… - Pediatric …, 2022 - Wiley Online Library
Introduction Endemic coronaviruses have been found in acute bronchiolitis, mainly as a
coinfecting virus. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has …
coinfecting virus. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has …
Diagnosis of multisystem inflammatory syndrome in children by a whole-blood transcriptional signature
HR Jackson, L Miglietta… - Journal of the …, 2023 - academic.oup.com
Background To identify a diagnostic blood transcriptomic signature that distinguishes
multisystem inflammatory syndrome in children (MIS-C) from Kawasaki disease (KD) …
multisystem inflammatory syndrome in children (MIS-C) from Kawasaki disease (KD) …
[HTML][HTML] Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the …
Background Young children living with HIV have few treatment options. We aimed to assess
the efficacy and safety of dolutegravir-based antiretroviral therapy (ART) in children …
the efficacy and safety of dolutegravir-based antiretroviral therapy (ART) in children …